Cosmo Pharmaceuticals NV banner

Wall St Price Targets

CMHC Price Forecast
Based on 8 analysts

+119% Upside
from CHf53.5 today

Cosmo Pharmaceuticals NV (CMHC)’s 12-month stock price forecast through November 2027 has a consensus target of CHf117.3, implying 119% upside. The forecast is based on price targets from 8 Wall Street analysts.

CMHC Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CMHC yet.

Cosmo Pharmaceuticals NV Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CMHC's stock price target?
Price Target
117.3 CHF

According to Wall Street analysts, the average 1-year price target for CMHC is 117.3 CHF with a low forecast of 80.8 CHF and a high forecast of 168 CHF.

What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 38%.

What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 44%.

Back to Top